Large infiltrative hepatocellular carcinomas: Treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection

Radiology

Volumn 234, Issue 1, 2005, Pages 299-309

  Seror, Olivier ^a,b   N'Kontchou, Giselle ^a   Haddar, Djamel ^a   Dordea, Marius ^a   Ajavon, Yves ^a   Ganne, Nathalie ^a,b   Trinchet, Jean Claude ^a,b   Beaugrand, Michel ^a   Sellier, Nicolas ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ACUTE PANCREATITIS; ADULT; AGED; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; INJECTION; LIVER ABSCESS; LIVER CELL CARCINOMA; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHANOL; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 10644269963     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2341031008     Document Type: Review

References (41)

1. Livraghi T. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Hepatogastroenterology 2001; 48:20-24.
2. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003; 237:171-179.
3. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
4. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240.
5. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
6. Yamanaka N, Takata M, Tanaka T, et al. Evolution of and obstacles in surgical treatment for hepatocellular carcinoma over the last 25 years: differences over four treatment eras. J Gastroenterol 2000; 35:613-621.
7. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37:429-442.
8. Gamma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: metaanalysis of randomized controlled trials. Radiology 2002; 224:47-54.
9. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739.
10. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
11. Bronowicki JP, Vetter D, Dumas F, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients. Cancer 1994; 74:16-24.
12. Takayasu K, Shima Y, Muramatsu Y, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 163:345-351.
13. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme). Lancet 1998; 352:17-20.
14. Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multidetector row helical CT. Radiology 2001; 218:763-767.
15. Lencioni R, Pinto F, Armillotta N, Bartolozzi C. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996; 201:353-358.
16. Imamura M, Shiratori Y, Sato S, et al. Percutaneous hepatic Infarction therapy for hepatocellular carcinoma. AJR Am J Roentgenol 1998; 171:1031-1035.
17. Lin ZY, Wang JH, Hsieh MY, et al. Percutaneous ethanol injection of the supplying artery to hepatocellular carcinoma that is not amenable to conventional treatment. Br J Radiol 2000; 73:833-839.
18. Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT. Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 2002; 224:542-547.
19. O'Riordan D, McAllister H, Sheahan BJ, MacErlean DP. Hepatic infarction with absolute ethanol. Radiology 1984; 152:627-630.
20. Doppman JL, Girton ME. Bile duct scarring following ethanol embolization of the hepatic artery: an experimental study in monkeys. Radiology 1984; 152:621-626.
21. Ekelund L, Lin G, Jonsson N, Kaude JV. Partial ablation of the kidney by intraarterial ethanol in domestic swine. Urol Radiol 1983; 5:233-241.
22. Takebayashi S, Hosaka M, Kubota Y, Ishizuka E, Iwasaki A, Matsubara S. Transarterial embolization and ablation of renal arteriovenous malformations: efficacy and damages in 30 patients with long-term followup. J Urol 1998; 159:696-701.
23. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003; 38(suppl 1): S136-S149.
24. 41st World Medical Assembly Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24:606-609.
25. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 European Association for the Study of the Liver Conference. J Hepatol 2001; 35: 421-430.
26. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48:251-259.
27. Allgaier HP, Deibert P, Olschewski M, et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection: a single-center analysis including 132 patients. Int J Cancer 1998; 79:601-605.
28. Yasuda S, Ito H, Yoshikawa M, et al. Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy. Int J Oncol 1999; 15:467-473.
29. Livraghi T, Lazzaroni S, Pellicano S, Ravasi S, Torzilli G, Vettori C. Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia. AJR Am J Roentgenol 1993; 161:1065-1069.
30. Lencioni R, Cioni D, Uliana M, Bartolozzi C. Fatal thrombosis of the portal vein following single-session percutaneous ethanol injection therapy of hepatocellular carcinoma. Abdom Imaging 1998; 23:608-610.
31. Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998; 83: 48-57.
32. Giorgio A, Tarantino L, Mariniello N, et al. Percutaneous ethanol injection under general anaesthesia for hepatocellular carcinoma: 3 year survival in 112 patients. Eur J Ultrasound 1998; 8:201-208.
33. Tapani E, Soiva M, Lavonen J, Ristkari S, Vehmas T. Complications following high-dose percutaneous ethanol injection into hepatic tumors. Acta Radiol 1996; 37:655-659.
34. Chan MK, Kwok PC, Chan SC, Lam TW, Lo KK, Lam CL. Percutaneous ethanol injection as a possible curative treatment for malignant portal vein thrombosis in hepatocellular carcinoma. Cardiovasc Intervent Radiol 1999; 22:326-328.
35. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction: a prospective controlled study. Cancer 1997; 79:2087-2094.
36. Konishi M, Ryu M, Kinoshita T, Inoue K. Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 2001; 48:1421-1424.
37. Rabe FE, Yune HY, Richmond BD, Klatte EC. Renal tumor infarction with absolute ethanol. AJR Am J Roentgenol 1982; 139: 1139-1144.
38. Yamakado K, Nakatsuka A, Tanaka N, Matsumura K, Takase K, Takeda K. Long-term follow-up arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma. J Vasc Interv Radiol 1999; 10: 641-647.
39. Wilson SR, Burns PN. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging. Semin Liver Dis 2001; 21:147-159.
40. Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003; 180:143-149.
41. Boehm T, Malich A, Goldberg SN, et al. Radio-frequency ablation of VX2 rabbit tumors: assessment by using contrast-enhanced harmonic power Doppler US. Radiology 2002; 225:815-821.